Session 3: Can the Best Practice Tariff and price benchmarking lead to better care? Elaine Young Director of Operations National Joint Registry & Peter.

Slides:



Advertisements
Similar presentations
Quality Accounts: Stakeholder Engagement. Introduction.
Advertisements

Cancer Registration and Health Service Regulation Dr Jenifer A E Smith.
Local Improvement following National Clinical Audit The View from a National Clinical Audit Provider – the Health & Social Care Information Centre.
Local Improvement following National Clinical Audit The View from a National Clinical Audit Provider – the Health & Social Care Information Centre.
Slides produced by the MBR Project Team
Making it Happen A Regional Perspective Steve Fairman Director of Improvement & Efficiency South Central SHA King’s Fund, 17 January 2011.
The Dislocation of Finance and Medical Device Innovation Ben Gooding, FRCS Consultant Orthopaedic Surgeon Clinical Lead, Circle Nottingham.
28th March 2013 Debbie Newton Chief Operating & Finance Officer
Adrian Dwyer Founder and former CEO Meridian Technique Ltd.
Right First Time: Update. Overview Making sure Sheffield residents continue to get the best possible health services is the aim of a new partnership between.
Practice based commissioning in Sutton and Merton PCT George Burns Practice Based Commissioning Development Manager
Alice Taylor BMedSci (Hons) Final Year Student Nottingham Medical School Professor Harold Ellis Medical Student Prize for Surgery 2010.
Using Payment by Results to commission better quality clinical care Eileen Robertson Payment by Results (PbR) Development Team.
Introducing the NHS Change Model. Why the NHS needs a Change Model Massive change in the NHS over past 10 years – much more to come Massive change now.
How can the Pharma Industry assist the NHS in constrained times? Can Pharma help with QIPP? PDIG meeting, 10 June 2010 Alison Clough Commercial & Communications.
The Health Roundtable 3-3b_HRT1215-Session_MILLNER_CARRUCAN_WOOD_ADHB_NZ Orthopaedic Service Excellence – Implementing Management Operating Systems Presenter:
Towards a ANZ Hip Fracture Registry “Quality Care Costs Less”
Equity and excellence: Liberating the NHS. Background Published in July 2010, the White Paper ‘Equity and Excellence: Liberating the NHS’ outlined our.
HQIP update and patient and public involvement Kim Rezel PPI lead.
Accessing NJR Data Inez Dunn NJR Regional Coordinator North West England.
October 2004 Screening and Surveillance of routine data Adrian Cook.
Financial Management for Budget Holders
Mental Health Collaborative PAYMENT BY RESULTS BRIEF UPDATE.
National and Local Clinical Audit 30/04/2015 Kate Godfrey Director of Operations QI and Development.
Dutch Orthopaedic Surgery Introduction of the country and the specialty.
The National Mastectomy and Breast Reconstruction Audit Key findings of the Third Annual Report Slides produced by the MBR Project Team. © The National.
Chairman, Pharmaceutical Market Support Group
© Institute for Fiscal Studies and Nuffield Trust, 2013 May 2013 Public payment and private provision The changing landscape of health care in the 2000s.
Implementing Surgical Surveillance with icnet ng.
Commissioning for Culture, Health and Wellbeing Ian Tearle Head of Health Policy Directorate of Public Health, NHS Devon Wednesday 7 th March 2012.
Effects of implementing Shared Decision Making in Knee replacement pathway Alan Nye Neil Parkinson.
A quick guide to CQC registration May Key concepts This quick overview of key concepts will help you decide what registration means for you:  What.
Health Strategy Management Contracting and Commissioning 5th February 2015 Pam Kaur Group Finance Manager University Hospitals Coventry & Warwickshire.
Dr. Christof Veit BQS Institut for Quality and Patient Safety Dusseldorf / Hamburg Quality and Regulation. Experiences from the German Health Care System.
Having your say within the new NHS health structures.
Patient Opinion and the Commissioning Support Units.
Transforming Community Services Commissioning Information for Community Services Stakeholder Workshop 14 October 2009 Coleen Milligan – Project Manager.
Influencing clinical commissioning through networks CSP English Regional Networks (ERN) – Development Event September 2012 Dawn Smith AHP Advisor NHS Clinical.
California Pay for Performance: Reporting First Year Results and The Business Case for IT Investment Lance Lang, MD Health Net, California November 18,
© Nuffield Trust 24 October 2015 NHS payment reform: evolving policy and emerging evidence Chief Economist: Anita Charlesworth.
4/24/2017 Health and Social Care Reform in Greater Manchester Developing a commissioning strategy for Primary Care Rob Bellingham — Director of Commissioning.
Choice of Hospital Patient Choice Jonathan Marron 5th May 2004.
Counting the cost Caring for people with dementia on hospital wards.
NHS Benchmarking Data Susan Hamilton Consultant in Public Health South Gloucestershire Council.
Performance Position July Delivering the right care, at the right time, in the right place CONTEXT Ambulance service significant activity increase.
Daniel J. Berry MD Chair, AJRR Board of Directors AAHKS Annual Meeting Dallas, Texas November 7, 2015.
Introducing Transparency to the use of Medical Device Implants Tom Williams, Executive Director Integrated Healthcare Association (IHA) The Quality Colloquium.
Caring for you...closer to home Hertfordshire Community NHS Trust Health Scrutiny Committee Update 13 December 2011 Derek Smith – Interim Chief Executive.
Innovation Poster Session
Practice Based Commissioning. Who We Are Large PBC Consortium - 75 Practices, 351 GPs, 652,000 population Majority of Northamptonshire covered4 locality.
Payment by Results in the UK National Health Service Charles Carson April 2008 Development of National Coding Standards within the Czech DRG System.
NUH Clinical Strategy 2010 Dementia. 1 The story In February 2009 the National Dementia Strategy was launched. It is a five year plan to transform the.
Autumn Staff briefings As a NHS patient, care is provided free at the time you need it, whether this is from a hospital or community nurse or.
Training for organisations participating in Peer Review of Paediatric Diabetes.
Creating incentives for better quality: Lessons from the English NHS Jennifer Field, Associate Director National Institute for Health and Clinical Excellence.
PROMs Martin Orton – NHS Information Centre. Overview PROMs Overview IC’s central role in implementation –Matching & linking to HES & NJR –Applying the.
National Clinical Audit and Patients Outcome Programme (NCAPOP) Richard Arnold Clinical Programme Lead, NHS England.
Quality Indicators Martin Orton – NHS IC & Arun Bhoopal DH Medical Directorate.
National Stroke Audit Rehabilitation Services 2016
American Joint Replacement Registry
Professor David Parkin King’s College London
American Joint Replacement Registry
How Bundled Payments Change Reimbursement Landscape
An introduction to ACSA
Irish Medical Device Association John O’Dwyer, Chief Executive
Connect and learn more at
Allied Health Improvement Group (B2)
Knee Replacement Market Knee Replacement Market.
Hip Replacement Market Hip Replacement Market.
Presentation transcript:

Session 3: Can the Best Practice Tariff and price benchmarking lead to better care? Elaine Young Director of Operations National Joint Registry & Peter Howard Orthopaedic surgeon member, NJR Steering Committee and Chairman, NJR Surgeon Outlier Sub-committee

About us The National Joint Registry for England, Wales and Northern Ireland Largest arthroplasty register in the world Hold more than 1.75 million records covering hip, knee, ankle, elbow and shoulder joint replacements Monitor the performance of implants, hospitals and surgeons Collaborating nationally (MHRA, CQC, Monitor) Collaborating internationally – a growing agenda (FDA, EU, international orthopaedic societies)

Best Practice Tariff (BPT)

New BPT For hip and knee replacement surgery in England Started April 2014 NJR data reported at hospital-level quarterly, on NHS-funded procedures in England Two NJR measures contribute – Compliance – Patient consent National PROMs data also forms part of the tariff requirements

BPT leading to better care? Through use of the tariff we hope to see improved: Data completeness – allowing a full picture of activity and performance to be reported Data quality – improving the active consent process to ensure we have patient details to monitor outcomes i.e. linking primary and revision operations together to calculate revision rates Best practice and engagement – organisations given financial incentive for their participation in national audit

BPT – learning so far Though it is early days for the NJR: Intention to increase the levels of compliance and patient consent required to drive up standard practice In 2015/16, the requirements for compliance will increase Impact - large number of trusts have already contacted the NJR to enter historical data

Price benchmarking

Background to price benchmarking Quality, Innovation, Productivity and Prevention (QIPP) Collaboration with the QIPP team at the DH Price benchmarking is one initiative that forms part of the QIPP programme to support clinical teams and NHS organisations to improve the quality of care they deliver while making efficiency savings

Background to price benchmarking Overview Initial pilot covering five hospitals, moving to 30 additional organisations across England and Wales Award winning initiative for benchmarking, Best Practice Institute 2013 Following this success, the pilot is now rolling out nationally as a free of charge NJR service – Trusts also have the option to buy enhanced reporting services, dependent on their requirements

Price benchmarking Objectives Provide local and national insight into the relative cost effectiveness of joint replacement surgery by individual prosthesis To enable providers to develop action plans around exploitation of this data to improve cost effectiveness of joint replacement surgery

Relating price to care Lower Cost Better Outcome Higher Cost Better Outcome Higher Cost Lower Outcome Lower Cost Lower Outcome At the heart of the pilot, was the intent to examine patient outcomes, not just cost.

What we set out to look at Measure price of implants Measure outcome (multi-faceted) Visualise this data to attempt to understand relationships between cost and outcome by implant Recognise that ‘comparisons’ need to be cautioned relative to volume and case-mix

What data? NJR Patient Reported Outcome HES/SUS Local Prosthesis Price Prosthesis Revision Outcome Hospital Volume of activity at hospital Patient Age and Sex demographic 12 month PROM Pre-operative score 6 month Health gain (PROM) Length of Stay Local Prosthesis Price

Implant costs data analysis 35 Trusts/units 5 largest manufacturers Annual spend on implants

DistributorCount of Priced ComponentsTotal Price Biomet9,992£4,511,333 DePuy34,273£13,681,324 Smith & Nephew5,125£2,225,748 Stryker17,854£5,999,144 Zimmer6,537£2,708,850 Other125£30,286 TOTAL73,906£29,156,685 Findings: total spend and usage

Findings £29m annual spend in hip and knee implants across the 35 organisations with the 5 suppliers included in the pilot Average hip implant cost - £1,368 – averages range from £800 - £2150 Average knee implant cost - £1,395 – average range from £ £1950

Findings If all 35 trusts purchased these components paying at most the AVERAGE price, the annual saving across the trusts would be £1.98m at the BEST price the annual saving would be £7.76m

Findings Link between volume purchased and cost paid is weak In many cases, prices paid not directly related to volume even to same company In any trust there is a wide variation in the average cost of implants between surgeons – Driven by usage of different implants/manufacturers

Trusts Trust Max implant cost Trust Min implant cost Trust Average implant cost No or primary procedures undertaken Variation in Implant Cost – Primary Knees

Trusts Procedure Device Costs by Trust - HIPS

Findings – Hip Stem Brand Pricing by Trust

Findings Wide variation in the average cost of implants between surgeons Wide variation in implant usage within single trusts

What did participants say Clinical Can I see my detailed data? Which procedure cost x and why? I wasn’t aware that component x cost more than component y! Can we link with clinical outcomes data / ODEP ratings for products? Procurement Who is paying £x for product y! I have alerted supplier x to the data and asked them to explain. Can we model the cost implications if we migrate to supplier x? Management Why do we pay more for product x? Who is consultant x?

What is happening now in Trusts Each Trust has now been invited to submit data to the scheme and receive an individual pricing report

How can this contribute to better care? Managing device costs ensures best use of finite healthcare resources Supports trusts and surgical teams in using data to evidence device choice Supports trusts in developing implant usage protocols Enhances evidence-based discipline around implant choice

Future study options Correlation with other variables – PROMS – Revision rates – Length of stay – Readmission

Thank you Mr Peter Howard Orthopaedic surgeon NJR Steering Committee Elaine Young Director of operations, National Joint Registry